Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 12.10

Unadjusted Graft Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2007 - 2008) (Tx 2007 - 2008) (Tx 2003 - 2008) (Tx 1998 - 2008)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,931 91.6% 0.5% 2,931 81.5% 0.7% 7,948 51.2% 0.7% 12,650 26.1% 0.7%
Lung Diagnosis Group Group A: Obstructive Lung Disease 1,046 92.1% 0.8% 1,046 82.4% 1.2% 3,275 53.4% 1.1% 5,871 23.8% 1.0%
Group B: Pulmonary Vascular Disease 124 84.7% 3.2% 124 79.0% 3.7% 336 44.9% 3.7% 576 35.0% 2.9%
Group C: Cystic Fibrosis or Immunodef. Disorders 414 94.7% 1.1% 414 84.0% 1.8% 1,192 51.0% 1.8% 1,924 33.2% 1.7%
Group D: Restrictive Lung Disease 1,271 90.9% 0.8% 1,271 80.1% 1.1% 2,955 49.5% 1.3% 3,948 24.6% 1.6%
Group E: Age Less Than 12 27 92.6% 5.0% 27 81.5% 7.5% 99 49.0% 6.1% 189 27.6% 5.0%
Other Diagnosis 49 89.8% 4.3% 49 87.8% 4.7% 91 52.1% 7.9% 142 38.4% 6.2%


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.